Type 1 Diabetes (T1D)
89
46
49
12
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 89 trials
100.0%
+13.5% vs benchmark
6%
5 trials in Phase 3/4
0%
0 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (89)
Integrating New Skills Into Diabetes Education With CGM
AI-Assisted Remote Insulin Pump Optimization in T1DM
Adapting Single Sessions Interventions for Type 1 Diabetes
Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
Universal Type 1 Diabetes Screening in Pediatrics
Dietary Approaches for the Management of Overweight and Obesity in Type 1 Diabetes
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
Automated Insulin for Management of Intrapartum Glycemia
INNODIA Family & Friends Early-Stage T1D Detection Protocol
Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease
Platform Trial in Stage 1 Diabetes: Comparing Golimumab vs Placebo
Circadian Mechanisms, Glucose, and CV Risks in T1D
PRISE (Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation in New, Recent, and Established Onset Type 1 Diabetes Treated With Human Anti-Thymocyte Globulin [h-ATG]) Study
Efficacy of Islet Re-transplantation After Failure of Beta-cell Replacement
Finding Immune Nascent Type 1 Diabetes
Telemedicine for Reach, Education, Access, and Treatment for Diabetes Self-Management Education and Support
Insulin Delivery With Self-Adjusting Closed-Loop and Behavioral Glycemic Control Enhanced by Prediction
Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
A Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesity, and Participants With Type 1 Diabetes With Overweight or Obesity